| Primary |
| Lung Neoplasm Malignant |
15.2% |
| Non-small Cell Lung Cancer |
13.3% |
| Premedication |
12.4% |
| Ovarian Cancer |
11.9% |
| Small Cell Lung Cancer Stage Unspecified |
7.9% |
| Lung Adenocarcinoma |
6.8% |
| Non-hodgkin's Lymphoma |
6.3% |
| Uterine Cancer |
5.0% |
| Neuroblastoma |
2.7% |
| Lymphoma |
2.6% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
2.1% |
| Cervix Carcinoma |
1.9% |
| Germ Cell Cancer |
1.9% |
| Langerhans' Cell Granulomatosis |
1.8% |
| Adult T-cell Lymphoma/leukaemia |
1.6% |
| Neoplasm Malignant |
1.6% |
| Breast Cancer Metastatic |
1.5% |
| Breast Cancer |
1.2% |
| Pleural Mesothelioma |
1.2% |
| Hepatoblastoma |
1.0% |
|
| Interstitial Lung Disease |
19.4% |
| Malignant Neoplasm Progression |
8.4% |
| Vomiting |
8.4% |
| Anaphylactic Shock |
6.8% |
| Hypersensitivity |
6.8% |
| Pneumothorax |
6.3% |
| Death |
4.7% |
| Neutropenia |
3.7% |
| Pneumonia |
3.7% |
| Renal Failure Acute |
3.7% |
| Inappropriate Antidiuretic Hormone Secretion |
3.1% |
| Pruritus |
3.1% |
| Pulmonary Embolism |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Extravasation |
2.6% |
| Febrile Neutropenia |
2.6% |
| Myelodysplastic Syndrome |
2.6% |
| Pancytopenia |
2.6% |
| Sepsis |
2.6% |
| Thrombocytopenia |
2.6% |
|
| Secondary |
| Non-small Cell Lung Cancer |
20.7% |
| Ovarian Cancer |
15.5% |
| Lung Neoplasm Malignant |
14.8% |
| Uterine Cancer |
6.4% |
| Premedication |
4.7% |
| Lung Adenocarcinoma |
4.3% |
| Prophylaxis |
3.7% |
| Cancer Pain |
3.2% |
| Prophylaxis Of Nausea And Vomiting |
3.0% |
| Lymphoma |
2.9% |
| Adult T-cell Lymphoma/leukaemia |
2.6% |
| Hypertension |
2.4% |
| Cervix Carcinoma |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Small Cell Lung Cancer Stage Unspecified |
2.0% |
| Constipation |
1.9% |
| Lung Adenocarcinoma Metastatic |
1.9% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
1.9% |
| Stem Cell Transplant |
1.8% |
| Breast Cancer |
1.8% |
|
| Interstitial Lung Disease |
18.2% |
| White Blood Cell Count Decreased |
10.9% |
| Pneumonitis |
7.3% |
| Malignant Neoplasm Progression |
5.9% |
| Pyrexia |
5.0% |
| Myelodysplastic Syndrome |
4.2% |
| Pneumonia |
4.2% |
| Acute Myeloid Leukaemia |
3.9% |
| Cerebral Infarction |
3.9% |
| Thrombocytopenia |
3.9% |
| Vomiting |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| Pulmonary Embolism |
3.6% |
| Gastrointestinal Perforation |
3.4% |
| Rash |
3.4% |
| Rhabdomyolysis |
3.4% |
| Somnolence |
3.1% |
| Urinary Tract Infection |
2.8% |
| Neuropathy Peripheral |
2.5% |
| Renal Failure Acute |
2.5% |
|
| Concomitant |
| Prophylaxis |
14.3% |
| Lung Adenocarcinoma Metastatic |
11.7% |
| Non-small Cell Lung Cancer |
7.4% |
| Lung Adenocarcinoma |
6.9% |
| Lung Adenocarcinoma Stage Iv |
6.0% |
| Prophylaxis Of Nausea And Vomiting |
6.0% |
| Pleural Mesothelioma Malignant |
5.2% |
| Cancer Pain |
4.9% |
| Chemotherapy |
4.5% |
| Allogenic Bone Marrow Transplantation Therapy |
3.9% |
| Hypertension |
3.8% |
| Product Used For Unknown Indication |
3.5% |
| Lung Neoplasm Malignant |
3.2% |
| Constipation |
3.1% |
| Ovarian Cancer |
3.0% |
| Breast Cancer Metastatic |
2.9% |
| Premedication |
2.9% |
| Breast Cancer |
2.6% |
| Uterine Cancer |
2.5% |
| Drug Use For Unknown Indication |
1.9% |
|
| White Blood Cell Count Decreased |
15.7% |
| Disease Progression |
9.9% |
| Pleural Effusion |
8.3% |
| Squamous Cell Carcinoma |
6.6% |
| Nausea |
5.8% |
| Interstitial Lung Disease |
5.0% |
| Platelet Count Decreased |
5.0% |
| Anaphylactic Shock |
4.1% |
| Death |
4.1% |
| Malignant Neoplasm Progression |
4.1% |
| Subarachnoid Haemorrhage |
4.1% |
| Vomiting |
4.1% |
| Peritonitis |
3.3% |
| Rash Pruritic |
3.3% |
| Renal Disorder |
3.3% |
| Tachycardia |
3.3% |
| Arterial Occlusive Disease |
2.5% |
| Dizziness |
2.5% |
| Eyelid Ptosis |
2.5% |
| Febrile Neutropenia |
2.5% |
|
| Interacting |
| Bronchial Disorder |
66.7% |
| Schizophrenia |
33.3% |
|
|
